Diphteria, Tetanus, Pertussis (Acellular Component) Booster (dtap) Vaccine, 2021-2023

Kort beskrivelse

The Ministry of Social Affairs and Health (hereinafter ‘STM’) and Finnish institute for health and welfare (hereinafter ‘THL’ or ‘Customer’) request your tender for diphteria, tetanus, pertussis (acellular component) booster (dtap) Vaccine belonging to the National Vaccination Programme in Finland. The contract period is about 2 years 2021-2023. The procurement contains one 2-year option period to extend the contract for the periods 2023 and 2024. Estimated quantity for the contract period including option is 455 000 doses. Customer reserves the right to increase or decrease the ordered numbers of doses by up to 20 %. The contract will be awarded to one supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition. Please note that all times given in the call for tender refer to local time in Finland. Tender annexes: Annex 1 Contract Annex 2 Handi Service Annex 3 JYSE 2014 Supplies (Updated April 2017) (link).